Showing results (61-70 of 263) with videos related to
Sort By:
Pageof 27
American Journal of Clinical Oncology|February 1, 1996
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot studyM Zambetti, M Terenziani, C Bartoli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer InstituteG Bonadonna, P Valagussa, C Brambilla, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's diseaseL Devizzi, A Santoro, V Bonfante, et al.Breast Cancer Research and Treatment|January 1, 1986
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancerR Silvestrini, M G Daidone, G Di Fronzo, et al.International Journal of Radiation Oncology, Biology, Physics|July 1, 1988
Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapyE Bajetta, P Valagussa, G Bonadonna, et al.Breast Cancer Research and Treatment|January 1, 1985
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerG Bonadonna, P Valagussa, A Rossi, et al.Breast Cancer Research and Treatment|November 1, 1987
Four-drug sequential regimen in advanced breast cancerL Ferrari, E Bajetta, L Gianni, et al.European Journal of Cancer & Clinical Oncology|August 1, 1989
Cell kinetics as a prognostic indicator in node-negative breast cancerR Silvestrini, M G Daidone, P Valagussa, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experienceS Viviani, G Bonadonna, A Santoro, et al.International Journal of Cancer|July 18, 2000
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancerR Silvestrini, A Luisi, M Zambetti, et al.Pageof 27